About Us

Ravi Anand has been the Company’s Chief Medical Officer since May 2005.  He received his university education in New Delhi, India and his medical training in the specialties of psychiatry and neurology in the United States.  For over 20 years,  Dr. Anand has worked in international drug development and registration departments of major pharmaceutical companies, including F. Hoffman-La Roche (Switzerland), Sandoz/Novartis (United States) and Organon (Netherlands).  From 1993 to 1997, he was the Medical Director of CNS, Clinical Research at Sandoz Research Institute.  From 1997 to 2001, he served as the international head of CNS Medical Affairs at Novartis.  From 2001 to 2003, he served as the global head of CNS Clinical Research at Organon.  Between 2003 and 2005, Dr. Anand was an independent consultant.

During his tenure in the pharmaceutical industry Dr. Anand has worked in all phases (I through III) of drug development as well as in medical commercialisation (phase IV).  Overall, he has been responsible for the conduct of clinical trials in over 30 countries.  He has been involved in over 30 investigational new drug applications, and over seven international new drug applications.  He has published extensively, including over 50 papers and 200 abstracts, posters and presentations